The UNTOUCHED study set out to evaluate the IAS rate for S-ICD in a more typical ICD patient population, using standardized programming and enhanced discrimination algorithms. To understand the results, you must know how Nelson Rockefeller died.

“Clearly, [S-ICD] is a game changer … rivaling or bettering transvenous systems or anything else that we have out there.” Dr. Michael Gold, UNTOUCHED principal investigator

For more information regarding S-ICD and its indications for use, visit bostonscientific.com/sicd. For more information regarding S-ICD usage within the EU, visit bostonscientific.eu/s-icd. For more S-ICD implantation resources and best practices, visit sicdtraining.com.